Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Jones
Pnd83 - Health Resource Utilization Across Stages of Alzheimer’s
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparison of Informal Caregiving Time Required by Alzheimer's Disease Patients and Mild Cognitive Impairment Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd117 - Physician Reported Adherence in Ms Patients Treated With Injectable Platform Therapies Versus Delayed-Release Dimethyl Fumarate: Findings From a Real-World Cross-Sectional Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral DMF Report a Better Quality of Life Compared to Patients on Platform Therapies as Measured by Eq-5d
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd155 - Reduced Relapse Rates and Improved Quality of Life for Relapsing-Remitting Multiple Sclerosis (Rrms) Patients Treated With Natalizumab vs Injectable Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd79 - Reduced Healthcare Resource Utilisation for Patients Treated With Delayed Release Dimethyl Fumarate vs Injectable Therapies: Findings From a Real-World Cross-Sectional Study of Ms Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd45 - Caregiver Need Across Stages of Alzheimer’s
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Impact of Disability on Activities of Daily Living, Productivity and Independency in Patients With Multiple Sclerosis- Findings From a 2016 Study in Europe and the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment With Interferon Beta-1a in Brazil Is Associated With Fewer Hospitalizations Due to Relapse, Better Adherence and a Better Response Compared to Other Platform Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd8 - Peginterferon Beta-1a Is Associated With Reduced Relapse Rates and Hospitalisations Due to Relapse Compared With Other First-Line Injectable Therapies for Multiple Sclerosis: Findings From a Real-World Cross-Sectional Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
1
2
›